Sign In To Continue
You have reached the guest article limit.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
Pacira BioSciences has issued a comprehensive statement addressing inaccuracies in DOMA Perpetual Capital Management’s recent assertions regarding the company’s intellectual property approach. Emphasizing its strong patent estate and ongoing legal actions, Pacira highlights key developments including patent reexaminat…
Share This Article
Ready-to-post copy includes the article link.
Pacira BioSciences Rebuts DOMA Perpetual’s Claims on Intellectual Property and Affirms Robust Patent Strategy Pacira BioSciences has issued a comprehensive statement addressing inaccuracies in DOMA Perpetual Capital Management’s recent assertions regarding the company’s intellectual property approach. Emphasizing its strong pat... Read the full IIPLA article: https://iipla.org/news/pacira-biosciences-rebuts-doma-perpetual-s-claims-on-intellectual-property-and-affirms-robust-patent-strategy